Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FEHZK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $184,551
Award facts
- Contract value 100% obligated
- $184,550.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 24, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $184,550.50, is set to be completed by September 25, 2025, and represents a child contract under the company's larger pharmaceutical supply vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The contract was competitively awarded with no set-aside designation, consistent with the company's track record of meeting federal procurement requirements through open competition.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including critical commodities for the Defense Health Agency and other federal healthcare systems. The current award for Xeljanz XR, a rheumatoid arthritis treatment, exemplifies the company's role in delivering specialized medications across multiple therapeutic domains to support federal medical supply chains.
Quick answers
Who was awarded contract SPE2DB25FEHZK?
SPE2DB25FEHZK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FEHZK worth?
The government has obligated $184,551 on SPE2DB25FEHZK.
Is contract SPE2DB25FEHZK an order under another contract?
Yes. SPE2DB25FEHZK is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEHZK competed?
The extent of competition for SPE2DB25FEHZK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award